The pivotal role of hepatocytes in drug discovery
- 1 May 2007
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 168 (1) , 2-15
- https://doi.org/10.1016/j.cbi.2006.11.002
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- In vitro–in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promisesBiochemical Pharmacology, 2006
- Methods To Evaluate Biliary Excretion of Drugs in Humans: An Updated ReviewMolecular Pharmaceutics, 2006
- AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMESDrug Metabolism and Disposition, 2005
- Validation of a semi-automated human hepatocyte assay for the determination and prediction of intrinsic clearance in discoveryJournal of Pharmaceutical and Biomedical Analysis, 2005
- An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytesChemico-Biological Interactions, 2004
- Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial librariesJournal of Pharmaceutical and Biomedical Analysis, 2004
- Induction of Drug Metabolising EnzymesClinical Pharmacokinetics, 2000
- Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liverHepatology, 1997
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973